Snowden Capital Advisors LLC Ionis Pharmaceuticals Inc Transaction History

Snowden Capital Advisors LLC

  • $3.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Jan 08, 2024
SELL
$41.6 - $63.4 $1.26 Million - $1.91 Million
-30,200 Closed
0 $0
Q3 2019

Jan 08, 2024
SELL
$59.06 - $72.15 $383,890 - $468,975
-6,500 Reduced 17.71%
30,200 $18.1 Million
Q2 2019

Jan 08, 2024
BUY
$62.09 - $86.14 $2.28 Million - $3.16 Million
36,700 New
36,700 $15 Million

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.1B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email